Taking BRAF V600E as an example, we found that in chronic myeloid leukemia, 22% of cells have BRAF V600E mutation (Figure 2C), which is consistent with previous research (50). Here, BRAF is linked to chronic myelogenous leukemia, BCR-ABL1 positive.